Khan, Shaheen
Khan, Saad A.
Luo, Xin
Fattah, Farjana J.
Saltarski, Jessica
Gloria-McCutchen, Yvonne
Lu, Rong
Xie, Yang
Li, Quan
Wakeland, Edward
Gerber, David E.
Article History
Received: 9 April 2018
Revised: 24 May 2018
Accepted: 1 June 2018
First Online: 31 October 2018
Competing interests
: The authors declare no competing interests.
: This study was approved by the UT Southwestern Institutional Review Board (IRB #STU 082015-053). All patients provided informed consent. The study was performed in accordance with the Declaration of Helsinki.
: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
: This study was given in part by a National Cancer Institute (NCI) Midcareer Investigator Award in Patient-Oriented Research (K24 CA201543-01 to D.E.G.), the David M.Crowley Foundation, the Peter Bradley Carlson Trust, the University of Texas Lung Cancer Specialized Program in Research Excellence (SPORE, P50-CA-070907-08S1 to D.E.G.) and the Cancer Prevention and Research Institute of Texas (CPRIT, RP15096), the Edwin L. Cox Distinguished Chair, the Human Genomics/Microarray Core and the Biomarker Research Core and Biostatistics Shared Resources at the Harold C.Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, which is supported in part by NCI Cancer Center Support Grant 1P30 CA142543-01.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).